These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18619498)

  • 1. Inclusion bodies: specificity in their aggregation process and amyloid-like structure.
    Morell M; Bravo R; Espargaró A; Sisquella X; Avilés FX; Fernàndez-Busquets X; Ventura S
    Biochim Biophys Acta; 2008 Oct; 1783(10):1815-25. PubMed ID: 18619498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and thermodynamic stability of bacterial intracellular aggregates.
    Espargaró A; Sabaté R; Ventura S
    FEBS Lett; 2008 Oct; 582(25-26):3669-73. PubMed ID: 18840434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-like properties of bacterial inclusion bodies.
    Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
    J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli.
    Sanagavarapu K; Nüske E; Nasir I; Meisl G; Immink JN; Sormanni P; Vendruscolo M; Knowles TPJ; Malmendal A; Cabaleiro-Lago C; Linse S
    Sci Rep; 2019 Mar; 9(1):3680. PubMed ID: 30842594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide.
    Bolognesi B; Cohen SI; Aran Terol P; Esbjörner EK; Giorgetti S; Mossuto MF; Natalello A; Brorsson AC; Knowles TP; Dobson CM; Luheshi LM
    ACS Chem Biol; 2014 Feb; 9(2):378-82. PubMed ID: 24199868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
    Kim W; Hecht MH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
    Villar-Piqué A; Espargaró A; Ventura S; Sabate R
    Biotechnol J; 2016 Jan; 11(1):172-7. PubMed ID: 26580000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.
    Oren O; Banerjee V; Taube R; Papo N
    Biochem J; 2018 Oct; 475(19):3087-3103. PubMed ID: 30213841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
    Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
    J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Chembiochem; ; . PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.